Ed Mathers
New Enterprise Associates Partner
Your Intro Paths to Ed Mathers
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Ed Mathers on
cbinvestment range
$200k - $40.0m
sweet spot
$10.0m
Ed Mathers's Past Investments (19)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Akouos | Seed Round | $7.5M (Lead) | Nov 2017 | |
| Trevi Therapeutics | Series C | $50.5M (Lead) | Jul 2017 | |
| Synlogic | Series C | $42M | May 2017 | |
| Mirna Therapeutics | Series D | $41.8M | Apr 2015 | |
| Synlogic | Series A | $29.4M (Lead) | Jul 2014 | |
| Lumena Pharmaceuticals | Series B | $45M (Lead) | Mar 2014 | |
| Lumos Pharma | Series A | $14M (Lead) | Feb 2014 | |
| Motus Therapeutics | Series B | $8M | Nov 2012 | |
| Intarcia Therapeutics | Series C | $160M | Nov 2012 | |
| Intarcia Therapeutics | Debt Financing | $50M | Nov 2012 |
Ed Mathers's Experience
Partner New Enterprise Associates2008 - Present
Partner New Enterprise Associates (NEA)2008 - Present
Ed Mathers's Education
NC State University Bachelor of Science (BS)
Ed Mathers's Media
No media found for Ed Mathers. Add it now.
Your Intro Paths to Ed Mathers
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Ed Mathers on
cb